Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY-NC-ND 4.0JAMA Network Open

Wastewater-Based Surveillance of Human Papillomavirus Genotype Diversity

Abstract

Importance: Human papillomaviruses (HPVs) account for more than 30% of infection-related cancers worldwide. Surveillance of circulating HPV genotypes at the population level remains limited because clinical monitoring primarily relies on cervical screening and does not capture infections in men or individuals outside screening programs. Objective: To assess whether wastewater-based epidemiology can monitor the diversity and temporal circulation of HPV genotypes at the population level. Design, Setting, and Participants: This is a cross-sectional study of raw wastewater collected twice weekly from January 24, 2024, to January 29, 2025, at a large wastewater treatment plant serving approximately 1 million population equivalents in the Paris, France, metropolitan area. Exposure: Population-level shedding of HPV DNA into wastewater. Main Outcomes and Measures: The primary outcomes were detection frequency, diversity, and temporal patterns of HPV genotypes in wastewater. HPVs of the genus Alphapapillomavirus were quantified using a broad-spectrum quantitative polymerase chain reaction assay and normalized using human-associated excretion markers (crAssphage and mitochondrial DNA). Twenty-eight HPV genotypes were screened using a multiplex polymerase chain reaction assay. Detection reproducibility was evaluated with McNemar tests (mid-P method); quantification reproducibility was evaluated using Wilcoxon signed-rank tests for censored data. Results: HPVs were detected in all 100 wastewater samples analyzed, with a mean concentration of 7.3 × 10 3 genome equivalents/L (range, 7.3 × 10 1 to 3.0 × 10 5 genome equivalents/L), showing moderate temporal variability over the study period. Twenty-seven HPV genotypes were identified, with a median of 6 genotypes per sample (range, 1-12). The most frequently detected genotypes were HPV-66 (97%; 95% CI, 93%-100%), HPV-6 (93%; 95% CI, 88%-97%), and HPV-53 (89%; 95% CI, 83%-95%). High-risk HPV-39 and HPV-56, which are not covered by current vaccines, were detected in 72% (95% CI, 63%-81%) and 58% (95% CI, 48%-68%) of samples, respectively, vs 21% (95% CI, 13%-29%) for HPV-16 and 5% (95% CI, 1%-10%) for HPV-18, both of which are vaccine targeted. Temporal modeling showed relatively stable viral circulation over the study period. Conclusions and Relevance: In this cross-sectional study of wastewater collected from a large urban population, wastewater-based epidemiology enabled population-level monitoring of HPV genotype circulation and complemented clinical surveillance by capturing infections across sexes and age groups. These findings suggested that this approach may facilitate evaluation of the effectiveness of HPV vaccination programs and serve as a scalable tool for monitoring HPV genotype diversity within the population.

Related

  1. An 11-Year Comprehensive Retrospective Study on the Prevalence and Genotype Distribution of Human Papillomavirus (HPV) in Women and Men in Türkiye and Northern Cyprus
    Tutku Taskinoglu, Zafer Yazici, Seda Gozel +4
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Prevalence, genotype distribution and associated factors of high-risk human papillomavirus among pregnant women in Eastern Ethiopia: a cross-sectional analysis nested within a population-based cohort study
    Fitsum Weldegebreal, Bodine Van Eenooghe, Desalegn Admassu Ayana +11
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  3. Divergent Human Papillomavirus Genotype Spectra in Three Indigenous Communities of Venezuela: Implications for Vaccine Choice and Cervical Screening.
    María Fátima Garcés, Jefferson Guzmán Silva, Daniel Aranguren +6
    Diseases (Basel, Switzerland)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. Prevalence and genotype distribution of human papillomavirus among 15,224 gynecological outpatients in Xuzhou, China, during 2023-2025.
    Shuo Chai, Lulu Hu, Wenting Fan +5
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  5. Prevalence and genotype distribution of human papillomavirus (HPV) among adolescent girls and young women in a high HIV burden rural area of South Africa: a cross-sectional survey
    M. Mthembu, K. Baisley, J. Busang +9
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
BibTeX
@article{michon2026wastewaterbased,
  title = {{Wastewater-Based Surveillance of Human Papillomavirus Genotype Diversity}},
  author = {Pauline Michon and Nicolas Cluzel and Yvon Maday and Jean-Luc Prétet and Sabrina Guérin and Rose Lecat and Thomas Thiébault and Vincent Maréchal},
  journal = {JAMA Network Open},
  year = {2026},
  month = sep,
  doi = {10.1001/jamanetworkopen.2026.35063},
  url = {https://hal.science/hal-05759816v1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Wastewater-Based Surveillance of Human Papillomavirus Genotype Diversity
AU  - Pauline Michon
AU  - Nicolas Cluzel
AU  - Yvon Maday
AU  - Jean-Luc Prétet
AU  - Sabrina Guérin
AU  - Rose Lecat
AU  - Thomas Thiébault
AU  - Vincent Maréchal
PY  - 2026
DA  - 2026/09/21
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.35063
UR  - https://hal.science/hal-05759816v1
AB  - Importance: Human papillomaviruses (HPVs) account for more than 30% of infection-related cancers worldwide. Surveillance of circulating HPV genotypes at the population level remains limited because clinical monitoring primarily relies on cervical screening and does not capture infections in men or individuals outside screening programs. Objective: To assess whether wastewater-based epidemiology can monitor the diversity and temporal circulation of HPV genotypes at the population level. Design, Setting, and Participants: This is a cross-sectional study of raw wastewater collected twice weekly from January 24, 2024, to January 29, 2025, at a large wastewater treatment plant serving approximately 1 million population equivalents in the Paris, France, metropolitan area. Exposure: Population-level shedding of HPV DNA into wastewater. Main Outcomes and Measures: The primary outcomes were detection frequency, diversity, and temporal patterns of HPV genotypes in wastewater. HPVs of the genus Alphapapillomavirus were quantified using a broad-spectrum quantitative polymerase chain reaction assay and normalized using human-associated excretion markers (crAssphage and mitochondrial DNA). Twenty-eight HPV genotypes were screened using a multiplex polymerase chain reaction assay. Detection reproducibility was evaluated with McNemar tests (mid-P method); quantification reproducibility was evaluated using Wilcoxon signed-rank tests for censored data. Results: HPVs were detected in all 100 wastewater samples analyzed, with a mean concentration of 7.3 × 10 3 genome equivalents/L (range, 7.3 × 10 1 to 3.0 × 10 5 genome equivalents/L), showing moderate temporal variability over the study period. Twenty-seven HPV genotypes were identified, with a median of 6 genotypes per sample (range, 1-12). The most frequently detected genotypes were HPV-66 (97%; 95% CI, 93%-100%), HPV-6 (93%; 95% CI, 88%-97%), and HPV-53 (89%; 95% CI, 83%-95%). High-risk HPV-39 and HPV-56, which are not covered by current vaccines, were detected in 72% (95% CI, 63%-81%) and 58% (95% CI, 48%-68%) of samples, respectively, vs 21% (95% CI, 13%-29%) for HPV-16 and 5% (95% CI, 1%-10%) for HPV-18, both of which are vaccine targeted. Temporal modeling showed relatively stable viral circulation over the study period. Conclusions and Relevance: In this cross-sectional study of wastewater collected from a large urban population, wastewater-based epidemiology enabled population-level monitoring of HPV genotype circulation and complemented clinical surveillance by capturing infections across sexes and age groups. These findings suggested that this approach may facilitate evaluation of the effectiveness of HPV vaccination programs and serve as a scalable tool for monitoring HPV genotype diversity within the population.
SN  - 2574-3805
ER  -